Literature DB >> 25766125

Alcohol Use Disorders and Community-Acquired Pneumococcal Pneumonia: Associated Mortality, Prolonged Hospital Stay and Increased Hospital Spending.

Miguel Gili-Miner1, Julio López-Méndez2, Luis Béjar-Prado3, Gloria Ramírez-Ramírez2, Ángel Vilches-Arenas2, José Sala-Turrens4.   

Abstract

INTRODUCTION: The aim of this study was to investigate the impact of alcohol use disorders (AUD) on community-acquired pneumococcal pneumonia (CAPP) admissions, in terms of in-hospital mortality, prolonged stay and increased hospital spending.
METHODS: Retrospective observational study of a sample of CAPP patients from the minimum basic datasets of 87 Spanish hospitals during 2008-2010. Mortality, length of hospital stay and additional spending attributable to AUD were calculated after multivariate covariance analysis for variables such as age and sex, type of hospital, addictions and comorbidities.
RESULTS: Among 16,202 non-elective admissions for CAPP in patients aged 18-74years, 2,685 had AUD. Patients admitted with CAPP and AUD were predominantly men with a higher prevalence of tobacco or drug use disorders and higher Charlson comorbidity index. Patients with CAPP and AUD had notably higher in-hospital mortality (50.8%; CI95%: 44.3-54.3%), prolonged length of stay (2.3days; CI95%: 2.0-2.7days) and increased costs (1,869.2€; CI95%: 1,498.6-2,239.8€).
CONCLUSIONS: According to the results of this study, AUD in CAPP patients was associated with increased in-hospital mortality, length of hospital stay and hospital spending.
Copyright © 2014 SEPAR. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  Alcohol use disorders; Costes; Costs; Estancia hospitalaria; Hospital stay; Mortalidad; Mortality; Neumonía neumocócica; Pneumococcal pneumonia; Trastornos asociados al consumo de alcohol

Mesh:

Substances:

Year:  2015        PMID: 25766125     DOI: 10.1016/j.arbres.2015.01.001

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  4 in total

1.  Pneumonia prevention in the elderly patients: the other sides.

Authors:  Najla Chebib; Clémence Cuvelier; Astrid Malézieux-Picard; Thibault Parent; Xavier Roux; Thomas Fassier; Frauke Müller; Virginie Prendki
Journal:  Aging Clin Exp Res       Date:  2019-12-31       Impact factor: 3.636

2.  Alcohol, Cannabis and Crossfading: Concerns for COVID-19 Disease Severity.

Authors:  Vijay Sivaraman; Morgan M Richey; Abm Nasir
Journal:  Biology (Basel)       Date:  2021-08-16

3.  A systematic review and meta-analysis of regional risk factors for critical outcomes of COVID-19 during early phase of the pandemic.

Authors:  Hyung-Jun Kim; Hyeontaek Hwang; Hyunsook Hong; Jae-Joon Yim; Jinwoo Lee
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

Review 4.  Epidemiology, virulence factors and management of the pneumococcus.

Authors:  Charles Feldman; Ronald Anderson
Journal:  F1000Res       Date:  2016-09-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.